4 Reasons To Buy, 2 Controversies Surrounding AstraZeneca
September 22, 2017 at 09:51 AM EDT
Bernstein upgraded shares of AstraZeneca plc (ADR) (NYSE: AZN), giving four reasons for its optimistic assessment. All the same, the ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.